logo

Royality Med Pharmaceuticals

Royality Med's mission is to fast-track the early stage of drug discovery using our predictive models of the human brain for therapeutic success. Many neurodevelopmental diseases do not have treatments due to a lack of a-priori knowledge of the underlying biology. Royality Med's technology is able to model these diseases to help enable the discovery of new targets and drugs, de-risking the current failure-prone cumbersome approach.
For inquiries, please contact us at
E-mail: info@royalitymed.com
 

Technologies

Major advances in science and technology are transforming the way scientists conduct research on diseases and are likely to improve diagnosis and treatment in the future. Digital solutions including automation, robotics-based strategies and virtual prediction systems have greatly contributed to increase throughputs and accelerate the discovery and development of new drugs.

Explore Current Technologies

Chemoproteomics
RNA-targeting small molecules
Diagnostic Imaging
PROTACs
Artificial-Intelligence

I would like to learn about Royality Med’s Pharmaceuticals discoveries to treat genetic diseases.